SAN FRANCISCO, Sept. 1, 2026 /PRNewswire/ — Amy Green, Hopelab’s Head of Research, has been named a 2026 Fierce 50 Health Equity honoree by Fierce Pharma, Fierce Biotech, and Fierce Healthcare. The Fierce 50 recognizes 50 individuals and organizations driving advancements in medicine, fostering innovation, and shaping the future of biopharma and health care.

“Now in its fourth year, the Fierce 50 continues to show that progress in this industry doesn’t come from just one place,” said Ayla Ellison, editor-in-chief of Fierce Life Sciences and Healthcare. “It’s showing up in the lab, in executive leadership, in community clinics and in advocacy work that never makes headlines. Whether it’s a biotech pushing a new therapy toward patients or a grassroots organization fighting for someone to get the care they need, these honorees remind us that impact takes a lot of different shapes. We’re honored to celebrate all of them.”

Dr. Green is a clinical psychologist with over two decades of experience in youth mental health, bringing expertise in implementation science, research methodology, and a commitment to advancing health equity. As Head of Research at Hopelab, she focuses on amplifying young people’s voices to guide the development of policies and programs that reflect their needs and lived experiences. Earlier this year, she testified before the California State Assembly Privacy and Consumer Protection Committee on the impact of social media on LGBTQ+ young people, drawing from Hopelab’s National Survey research and recent national poll on youth well-being. Previously, Dr. Green served as Vice President of Research at The Trevor Project, where she led research to advance crisis services, peer support programs, and advocacy efforts for LGBTQ+ young people.

“Amy’s recognition as a Fierce 50 honoree is a testament to the heart and rigor she contributes each and every day,” said Jaspal Sandhu, President and CEO of Hopelab. “Her extraordinary ability to bridge research with advocacy reflects her expertise and her commitment to building a future where young people are thriving. We’re incredibly proud to see her contributions recognized nationally.”

Chosen by the editors of Fierce Pharma, Fierce Biotech and Fierce Healthcare, this year’s Fierce 50 honorees reflect the breadth of talent and vision shaping the biopharma and health care industries today. From startups to established organizations, each has made a distinct contribution, whether by advancing scientific discovery, improving the health of communities, expanding access to care or reimagining how health care is delivered at a local level or on a global scale.

About Hopelab
Hopelab envisions a future where young people have equitable opportunities to live joyful and purposeful lives. As a researcher, investor, and convener, Hopelab is dedicated to fostering greater mental health and well-being outcomes for Brown, Black, and Queer young people. Learn more at hopelab.org.

About Fierce Pharma
Fierce Pharma is the go-to destination for the news and trends shaping the industry. Our focus daily is on news about approved drugs and every aspect of pharma’s operations as well as the people who move pharma forward. Our coverage also feeds longer-form content, podcasts and events. In staying on top of the news, our journalists have developed a loyal audience. Critically, we explain the news—often complicated technology or business maneuvers—and put it in context that brings it home for our readers and listeners in their work lives.

About Fierce Biotech
Fierce Biotech is the dominant B2B news brand for the industry. Every day, we track the companies, people and ideas reshaping biotech: from the discovery through clinical trials, approvals and commercialization, and the venture funding, partnerships, IPOs and M&A that power it all. That reporting fuels our long-form features, podcasts and events, where deal flow, data and on-the-ground insight come together into the fullest picture of where the industry is headed.

About Fierce Healthcare
At Fierce Healthcare, we deliver the news and analysis that healthcare can’t afford to miss. Our newsroom serves the people building, running, and reshaping this industry: hospital executives and physicians, payers, policymakers, researchers and the entrepreneurs betting on what comes next. Wherever healthcare is being disrupted, financed, regulated, or reinvented, we’re covering it, with breaking news, exclusive interviews and deep reporting that connects the dots between a boardroom decision and a patient’s bedside experience.

View original content to download multimedia:https://www.prnewswire.com/news-releases/amy-green-phd-recognized-as-a-2026-fierce-50-health-equity-honoree-302865611.html

SOURCE Hopelab